Identification of a novel binding partners for tumor suppressor PTEN by a yeast two-hybrid approach

Olena Gorbenko1, Vitaliy Kuznetsov, Olexandr Kukharenko

  • 1Institute of Molecular Biology and Genetics, NAS of Ukraine, Kyiv, Ukraine.

Eksperimental'Naia Onkologiia
|April 29, 2004
PubMed
Abstract

Insights

Researchers identified Adipocyte Enhancer Binding Protein 1 (AEBP1) as a novel PTEN-binding partner using yeast two-hybrid screening. This interaction is mediated by the C-terminal domain of PTEN and the N-terminal domain of AEBP1.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • PTEN is a critical tumor suppressor gene.
  • Identifying PTEN-binding partners is crucial for understanding its cellular functions.

Purpose of the Study:

  • To discover novel proteins that interact with PTEN.
  • To characterize the interaction domains between PTEN and its binding partners.

Main Methods:

  • Yeast two-hybrid screening was employed.
  • Bait constructs included full-length PTEN, its C-terminal domain, and mutants.
  • CDNA libraries from Colon Cancer, HeLa, and Mouse Embryo were screened.

Main Results:

  • Forty-three positive clones were identified and confirmed.
  • Sequence analysis revealed two clones encoding Adipocyte Enhancer Binding Protein 1 (AEBP1).

Conclusions:

  • PTEN interacts with AEBP1.
  • The interaction is mediated by PTEN's C-terminal and AEBP1's N-terminal domains.
  • The functional significance of this interaction requires further investigation.

Related Concept Videos